miR-206-G6PD axis regulates lipogenesis and cell growth in hepatocellular carcinoma cell
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-206-G6PD axis regulates lipogenesis and cell growth in hepatocellular carcinoma cell
Authors
Keywords
-
Journal
ANTI-CANCER DRUGS
Volume 32, Issue 5, Pages 508-516
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2021-03-19
DOI
10.1097/cad.0000000000001069
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR-206 inhibits cell proliferation, invasion, and migration by down-regulating PTP1B in hepatocellular carcinoma
- (2019) Qian Yang et al. BIOSCIENCE REPORTS
- Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans
- (2019) Li Che et al. GUT
- MicroRNA-206 serves as a tumor suppressor in pediatric acute myeloid leukemia by targeting Cyclin D1
- (2019) Hong Liu et al. PATHOLOGY RESEARCH AND PRACTICE
- The Redox Role of G6PD in Cell Growth, Cell Death, and Cancer
- (2019) Yang et al. Cells
- MicroRNA-206 regulates cell proliferation by targeting G6PD in skeletal muscle
- (2019) Aiwen Jiang et al. FASEB JOURNAL
- Targeting the pentose phosphate pathway increases reactive oxygen species and induces apoptosis in thyroid cancer cells
- (2019) Chien-Liang Liu et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Prognostic significance of G6PD expression and localization in lung adenocarcinoma
- (2018) Ryo Nagashio et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway
- (2018) Chunxiu Dai et al. BIOMEDICINE & PHARMACOTHERAPY
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- HCCDB: A Database of Hepatocellular Carcinoma Expression Atlas
- (2018) Qiuyu Lian et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- LINC00707 contributes to hepatocellular carcinoma progression via sponging miR-206 to increase CDK14
- (2018) Janfei Tu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Comprehensive molecular and immunological characterization of hepatocellular carcinoma
- (2018) Shu Shimada et al. EBioMedicine
- Lipid Metabolic Reprogramming in Hepatocellular Carcinoma
- (2018) Hayato Nakagawa et al. Cancers
- MicroRNA-206 prevents the pathogenesis of hepatocellular carcinoma by modulating expression of met proto-oncogene and cyclin-dependent kinase 6 in mice
- (2017) Heng Wu et al. HEPATOLOGY
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
- (2017) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- Overexpression of G6PD Represents a Potential Prognostic Factor in Clear Cell Renal Cell Carcinoma
- (2017) Qiao Zhang et al. Journal of Cancer
- miR-206 inhibits the growth of hepatocellular carcinoma cells via targeting CDK9
- (2017) Chi Pang et al. Cancer Medicine
- Emerging Role of the Pentose Phosphate Pathway in Hepatocellular Carcinoma
- (2017) Marta Anna Kowalik et al. Frontiers in Oncology
- Salvage Versus Primary Liver Transplantation for Early Hepatocellular Carcinoma
- (2016) Prashant Bhangui et al. ANNALS OF SURGERY
- Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis
- (2016) Marta Anna Kowalik et al. Oncotarget
- Lipid metabolic reprogramming in cancer cells
- (2016) S Beloribi-Djefaflia et al. Oncogenesis
- miR-206 inhibits metastasis-relevant traits by degrading MRTF-A in anaplastic thyroid cancer
- (2015) WEN-LONG ZHANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- G6PD downregulation triggered growth inhibition and induced apoptosis by regulating STAT3 signaling pathway in esophageal squamous cell carcinoma
- (2015) Xin Wang et al. TUMOR BIOLOGY
- MicroRNA-206 overexpression promotes apoptosis, induces cell cycle arrest and inhibits the migration of human hepatocellular carcinoma HepG2 cells
- (2014) WEIWEI LIU et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Tumor-suppressive microRNA-206 as a dual inhibitor of MET and EGFR oncogenic signaling in lung squamous cell carcinoma
- (2014) HIROKO MATAKI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Lipogenesis in cancer progression (Review)
- (2014) CATHERINE MOUNIER et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Variant G6PD levels promote tumor cell proliferation or apoptosis via the STAT3/5 pathway in the human melanoma xenograft mouse model
- (2013) Tao Hu et al. BMC CANCER
- MiR-206 inhibits gastric cancer proliferation in part by repressing CyclinD2
- (2013) Lin Zhang et al. CANCER LETTERS
- PTEN antagonises Tcl1/hnRNPK-mediated G6PD pre-mRNA splicing which contributes to hepatocarcinogenesis
- (2013) Xuehui Hong et al. GUT
- Hepatocellular Carcinoma
- (2011) Hashem B. El-Serag NEW ENGLAND JOURNAL OF MEDICINE
- MicroRNA-206 Targetsnotch3, Activates Apoptosis, and Inhibits Tumor Cell Migration and Focus Formation
- (2009) Guisheng Song et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started